Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.42 |
| ▸ | GAA | P10253 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 3/20 | 0.36 |
| ▸ | NPC1 | O15118 | 2/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2742437 | 0.73 | KDM4E (0.32) | ALDH1A1KDM4E | |
| SCHEMBL12830087 | 0.70 | ALDH1A1 (0.36) | MAPTALDH1A1HPGDTSHRHSD17B10 | |
| SCHEMBL2881048 | 0.66 | — | — | |
| SCHEMBL9487495 | 0.66 | ALDH1A1 (0.48) | MAPTGAAALDH1A1KDM4EHPGD | |
| SCHEMBL9487501 | 0.66 | ALDH1A1 (0.48) | MAPTGAAALDH1A1KDM4EHPGD | |
| SCHEMBL9486735 | 0.66 | ALDH1A1 (0.48) | MAPTGAAALDH1A1KDM4EHPGD | |
| SCHEMBL9486739 | 0.66 | ALDH1A1 (0.48) | MAPTGAAALDH1A1KDM4EHPGD | |
| SCHEMBL10414880 | 0.66 | ALDH1A1 (0.48) | MAPTGAAALDH1A1KDM4EHPGD | |
| SCHEMBL17200805 | 0.66 | ALDH1A1 (0.44) | MAPTGAAALDH1A1KDM4EHPGD | |
| SCHEMBL9389529 | 0.64 | ALDH1A1 (0.40) | MAPTGAAALDH1A1KDM4EHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120004386-A1 | CONJUGATED THIOPHENES HAVING CONDUCTING PROPERTIES AND SYNTHESIS OF SAME | UNIVERSITE DE MONTREAL (CA) | 2012-01-05 | — | — | US | disclosed |
| US-8034895-B2 | Conjugated thiophenes having conducting properties and synthesis of same | Université de Montréal (CA) | 2011-10-11 | — | — | US | disclosed |
| US-20070287842-A1 | Conjugated Thiophenes Having Conducting Properties and Synthesis of Same | UNIVERSITE DE MONTREAL (CA) | 2007-12-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070287842-A1 | Conjugated Thiophenes Having Conducting Properties and Synthesis of Same | DDT, DDC, TRPA1 | MAPT 233/4885GAA 2887/4885ALDH1A1 91/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.